Phyllis J. Goodman

28.5k total citations · 5 hit papers
160 papers, 13.2k citations indexed

About

Phyllis J. Goodman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Phyllis J. Goodman has authored 160 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Phyllis J. Goodman's work include Prostate Cancer Treatment and Research (68 papers), Prostate Cancer Diagnosis and Treatment (56 papers) and Antioxidant Activity and Oxidative Stress (23 papers). Phyllis J. Goodman is often cited by papers focused on Prostate Cancer Treatment and Research (68 papers), Prostate Cancer Diagnosis and Treatment (56 papers) and Antioxidant Activity and Oxidative Stress (23 papers). Phyllis J. Goodman collaborates with scholars based in United States, Canada and Australia. Phyllis J. Goodman's co-authors include Ian M. Thompson, Catherine M. Tangen, M. Scott Lucia, Charles A. Coltman, Scott M. Lippman, Howard L. Parnes, Leslie G. Ford, Lori M. Minasian, Alan R. Kristal and John J. Crowley and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Phyllis J. Goodman

154 papers receiving 12.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Influence of Finasteride on the Development of Prostate Cancer

2003 1.7k citations Ian M. Thompson, Phyllis J. Goodman et al. New England Journal of Medicine profile →
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

2004 1.7k citations Ian M. Thompson, Phyllis J. Goodman et al. New England Journal of Medicine profile →
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

1990 1.7k citations John S. Macdonald, Phyllis J. Goodman et al. New England Journal of Medicine profile →
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

1989 1.2k citations E. David Crawford, Phyllis J. Goodman et al. New England Journal of Medicine profile →
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

2006 658 citations Ian M. Thompson, Donna P. Ankerst et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Phyllis J. Goodman

Since Specialization

Citations

This map shows the geographic impact of Phyllis J. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis J. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis J. Goodman more than expected).

Fields of papers citing papers by Phyllis J. Goodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis J. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis J. Goodman. The network helps show where Phyllis J. Goodman may publish in the future.

Co-authorship network of co-authors of Phyllis J. Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis J. Goodman. A scholar is included among the top collaborators of Phyllis J. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis J. Goodman. Phyllis J. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Adverse Effects and Complications After Prostate Cancer Treatment 2024 ·JAMA Oncology ·Joseph M. Unger, Cathee Till, Catherine M. Tangen, Dawn L. Hershman, Phyllis J. Goodman, Michael LeBlanc, William E. Barlow, Riha Vaidya, Lori M. Minasian, Howard L. Parnes, Ian M. Thompson	9
2	Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Jeannette M. Schenk, Cathee Till, Marian L. Neuhouser, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Catherine M. Tangen	1
3	Change in plasma α-tocopherol associations with attenuated pulmonary function decline and with CYP4F2 missense variation 2022 ·American Journal of Clinical Nutrition ·Jiayi Xu, Kristin A. Guertin, Nathan Gaddis, (unknown), Robert S. Parker, (unknown), Alan R. Kristal, Kathryn B. Arnold, Phyllis J. Goodman, Catherine M. Tangen, Dana B. Hancock, Patricia A. Cassano	3
4	Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial 2020 ·Cancer Prevention Research ·Lauren M. Hurwitz, İbrahim Kulaç, Berrak Gümüşkaya, Javier Baena-Del Valle, (unknown), Fan Pan, Jun O. Liu, Michael Marrone, Kathryn B. Arnold, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Ian M. Thompson, Charles G. Drake, William B. Isaacs, William G. Nelson, Angelo M. De Marzo, Elizabeth A. Platz	7
5	Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial 2020 ·Cancer Prevention Research ·Kathleen C. Torkko, Cathee Till, Catherine M. Tangen, Phyllis J. Goodman, Xiaoling Song, Jeannette M. Schenk, M. Scott Lucia, Ulrike Peters, Adrie van Bokhoven, Ian M. Thompson, Marian L. Neuhouser	4
6	Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI 2019 ·Cancer Epidemiology ·Catherine M. Tangen, Jeannette M. Schenk, Cathee Till, Phyllis J. Goodman, Wendy E. Barrington, M. Scott Lucia, Ian M. Thompson	4
7	Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride 2018 ·Cancer Prevention Research ·James Y. Dai, Michael LeBlanc, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Catherine M. Tangen	2
8	Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT 2016 ·Cancer Epidemiology Biomarkers & Prevention ·June M. Chan, Amy K. Darke, Kathryn L. Penney, Catherine M. Tangen, Phyllis J. Goodman, Gwo-Shu Mary Lee, Tong Sun, (unknown), (unknown), James M. Rae, Eric A. Klein, Ian M. Thompson, Philip W. Kantoff, Lorelei A. Mucci	47
9	Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2014 ·Cancer Prevention Research ·Demetrius Albanes, Cathee Till, Eric A. Klein, Phyllis J. Goodman, Alison M. Mondul, Stephanie J. Weinstein, Philip R. Taylor, Howard L. Parnes, J. Michael Gaziano, Xiaoling Song, Neil Fleshner, Powel H. Brown, Frank L. Meyskens, Ian M. Thompson	49
10	Long-Term Survival of Participants in the Prostate Cancer Prevention Trial 2013 ·New England Journal of Medicine ·Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, Howard L. Parnes, Lori M. Minasian, Paul A. Godley, M. Scott Lucia, Leslie G. Ford	181
11	Finasteride Modifies the Relation between Serum C-Peptide and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial 2010 ·Cancer Prevention Research ·Marian L. Neuhouser, Cathee Till, Alan R. Kristal, Phyllis J. Goodman, A.T.M. Shamsul Hoque, Elizabeth A. Platz, Ann W. Hsing, Demetrius Albanes, Howard L. Parnes, Michaël Pollak	28
12	Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Elizabeth A. Platz, Cathee Till, Phyllis J. Goodman, Howard L. Parnes, William D. Figg, Demetrius Albanes, Marian L. Neuhouser, Eric A. Klein, Ian M. Thompson, Alan R. Kristal	133
13	Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention 2008 ·Cancer Prevention Research ·M. Scott Lucia, Amy K. Darke, Phyllis J. Goodman, Francisco G. La Rosa, Howard L. Parnes, Leslie G. Ford, Charles A. Coltman, Ian M. Thompson	72
14	Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach 2008 ·Cancer Prevention Research ·Mary W. Redman, Catherine M. Tangen, Phyllis J. Goodman, M. Scott Lucia, Charles A. Coltman, Ian M. Thompson	140
15	Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment 2007 ·The Prostate ·YoonJu Song, Catherine M. Tangen, Phyllis J. Goodman, Howard L. Parnes, M. Scott Lucia, Ian M. Thompson, Alan R. Kristal	6
16	Modeling the Effect of a Preventive Intervention on the Natural History of Cancer: Application to the Prostate Cancer Prevention Trial 2006 ·The International Journal of Biostatistics ·Paul F. Pinsky, Ruth Etzioni, Nadia Howlader, Phyllis J. Goodman, Ian M. Thompson	2
17	Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer 2006 ·JNCI Journal of the National Cancer Institute ·Ian M. Thompson, Chi Chen, Donna P. Ankerst, Phyllis J. Goodman, Catherine M. Tangen, Scott M. Lippman, M. Scott Lucia, Howard L. Parnes, Charles A. Coltman	217
18	Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma 1993 ·Investigational New Drugs ·W. Henwood Harvey, Thomas R. Fleming, Phyllis J. Goodman, (unknown), Saul E. Rivkin, John S. Macdonald	4
19	Treatment of stages B3 and C seminoma with chemotherapy followed by irradiation therapy 1992 ·Urology ·E. David Crawford, Phyllis J. Goodman, (unknown), Ronald L. Stephens, (unknown), (unknown), Anthony Y. Smith, (unknown)	3
20	A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study. 1990 ·PubMed ·Robert P. Whitehead, Thomas R. Fleming, John S. Macdonald, Phyllis J. Goodman, John R. Neefe, Thomas J. Braun, Lode J. Swinnen, Evan M. Hersh	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact